Phase III not necessary in biosimilars development? New MHRA guidance, will there be a "snowball effect"?

MHRA is one of the leading Health Authorities. The new MHRA guideline is straightforward about what has been discussed for a long time. The open question remains when other regulators (EMA, HC,...

01 January 1970 8,176 0 View